Follow
Stefanos Bonovas
Stefanos Bonovas
Humanitas University, Milan, Italy
Verified email at hunimed.eu
Title
Cited by
Cited by
Year
ECCO guidelines on therapeutics in Crohn's disease: medical treatment
J Torres, S Bonovas, G Doherty, T Kucharzik, JP Gisbert, T Raine, ...
Journal of Crohn's and Colitis 14, 4–22, 2020
5792020
Diabetes mellitus and risk of prostate cancer: a meta-analysis
S Bonovas, K Filioussi, A Tsantes
Diabetologia 47, 1071–1078, 2004
3422004
E‐learning for health professionals
A Vaona, G Rigon, R Banzi, KH Kwag, D Cereda, V Pecoraro, L Moja, ...
Cochrane Database of Systematic Reviews, CD011736, 2015
3272015
Effectiveness of computerized decision support systems linked to electronic health records: a systematic review and meta-analysis
L Moja, KH Kwag, T Lytras, L Bertizzolo, L Brandt, V Pecoraro, G Rigon, ...
American Journal of Public Health 104, e12–e22, 2014
3262014
Environmental risk factors for inflammatory bowel diseases: an umbrella review of meta-analyses
D Piovani, S Danese, L Peyrin-Biroulet, GK Nikolopoulos, T Lytras, ...
Gastroenterology 157, 647–659.e4, 2019
3252019
Biologic therapies and risk of infection and malignancy in patients with inflammatory bowel disease: a systematic review and network meta-analysis
S Bonovas, G Fiorino, M Allocca, T Lytras, GK Nikolopoulos, ...
Clinical Gastroenterology and Hepatology 14, 1385–1397.e10, 2016
3092016
Diabetes mellitus as a risk factor for primary open-angle glaucoma: a meta-analysis
S Bonovas, V Peponis, K Filioussi
Diabetic Medicine 21, 609–614, 2004
2682004
Use of statins and breast cancer: a meta-analysis of seven randomized clinical trials and nine observational studies
S Bonovas, K Filioussi, N Tsavaris, NM Sitaras
Journal of Clinical Oncology 23, 8606–8612, 2005
2502005
Biological agents for moderately to severely active ulcerative colitis. A systematic review and network meta-analysis
S Danese, G Fiorino, L Peyrin-Biroulet, E Lucenteforte, G Virgili, L Moja, ...
Annals of Internal Medicine 160, 704–711, 2014
2432014
Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis
S Minozzi, S Bonovas, T Lytras, V Pecoraro, M González-Lorenzo, ...
Expert Opinion on Drug Safety 15 (sup1), 11–34, 2016
2382016
ECCO guidelines on therapeutics in Crohn˘s disease: surgical treatment
M Adamina, S Bonovas, T Raine, A Spinelli, J Warusavitarne, A Armuzzi, ...
Journal of Crohn's and Colitis 14, 155–168, 2020
2302020
Statins and cancer risk: a literature-based meta-analysis and meta-regression analysis of 35 randomized controlled trials
S Bonovas, K Filioussi, N Tsavaris, NM Sitaras
Journal of Clinical Oncology 24, 4808–4817, 2006
2072006
Outbreak of West Nile virus infection in Greece, 2010
K Danis, A Papa, G Theocharopoulos, G Dougas, M Athanasiou, M Detsis, ...
Emerging Infectious Diseases 17, 1868–1872, 2011
2012011
Autochthonous Plasmodium vivax malaria in Greece, 2011
K Danis, A Baka, A Lenglet, W Van Bortel, I Terzaki, M Tseroni, M Detsis, ...
Eurosurveillance 16, pii=19993, 2011
1912011
Statins and the risk of colorectal cancer: a meta-analysis of 18 studies involving more than 1.5 million patients
S Bonovas, K Filioussi, CS Flordellis, NM Sitaras
Journal of Clinical Oncology 25, 3462–3468, 2007
1772007
Statin use and the risk of prostate cancer: a metaanalysis of 6 randomized clinical trials and 13 observational studies
S Bonovas, K Filioussi, NM Sitaras
International Journal of Cancer 123, 899–904, 2008
1612008
Early predictors of clinical deterioration in a cohort of 239 patients hospitalized for Covid-19 infection in Lombardy, Italy
M Cecconi, D Piovani, E Brunetta, A Aghemo, M Greco, M Ciccarelli, ...
Journal of Clinical Medicine 9, 1548, 2020
1602020
The effect of the plasminogen activator inhibitor-1 4G/5G polymorphism on the thrombotic risk
AE Tsantes, GK Nikolopoulos, PG Bagos, S Bonovas, P Kopterides, ...
Thrombosis Research 122, 736–742, 2008
1472008
The PROSIT-BIO Cohort: a prospective observational study of patients with inflammatory bowel disease treated with infliximab biosimilar.
G Fiorino, N Manetti, A Armuzzi, A Orlando, A Variola, S Bonovas, ...
Inflammatory Bowel Diseases 23, 233–243, 2017
1392017
Safety of Janus kinase inhibitors in patients with inflammatory bowel diseases or other immune-mediated diseases: a systematic review and meta-analysis
P Olivera, J Lasa, S Bonovas, S Danese, L Peyrin-Biroulet
Gastroenterology 158, 1554–1573.e12, 2020
1382020
The system can't perform the operation now. Try again later.
Articles 1–20